Legislative Strategies Group
John Coster, PhD, has joined the Legislative Strategies Group, where he is working with Merck and other pharmaceutical and health care groups. The firm's client list also includes Lilly, Hoffmann-La Roche, Amgen and the National Association of Chain Drug Stores. Coster was most recently director of public affairs at InterScience. He was formerly with NACDS, and from 1990-1994 he served as health advisor to Sen. Pryor (D-Ark.)
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth